合并巨大左心室的心脏瓣膜病治疗现状  

Treatment Status of Valvular Heart Disease with Giant Left Ventricle

作　　者：王湘 李刚 王水云 WANG Xiang;LI Gang;WANG Shuiyun(Department of Cardiac and Large Vascular Surgery,Fuwai Shenzhen Hospital,Chinese Academy of Medical Sciences,Shenzhen 518000,Guangdong,China)

机构地区：[1]中国医学科学院阜外医院深圳医院心脏大血管外科,广东深圳518000

出　　处：《心血管病学进展》2024年第9期769-772,共4页Advances in Cardiovascular Diseases

基　　金：深圳市医学重点学科建设经费资助(SZXK019)。

摘　　要：合并巨大左心室的心脏瓣膜病往往伴随着心功能不全,是手术治疗的重要危险因素之一。了解巨大左心室的评估以及相关病理生理改变,对把握患者的手术时机、改善患者长期预后至关重要。随着心肌保护、术中监测措施、人工瓣膜设计等综合因素的不断进步,常规瓣膜置换术仍是主要的手术方式并取得满意的效果,但近年来介入瓣膜植入技术取得快速发展,很可能为合并巨大左心室的心脏瓣膜病患者提供一种更安全的手术方式选择。Valvular heart disease with giant left ventricle is often accompanied by cardiac insufficiency,which is one of the important risk factors for surgical treatment.Understanding the evaluation of giant left ventricle and related pathophysiological changes is very important for grasping the timing of surgery and improving the long-term prognosis of patients.At the same time,with the continuous progress of myocardial protection,intraoperative monitoring measures,prosthetic valve design and other comprehensive factors,the conventional valve replacement is still the main surgical method and has achieved satisfactory results.The rapid development of interventional valve implantation technology in recent years is likely to provide a safer surgical option for patients with valvular heart disease and giant left ventricle.

关 键 词：巨大左心室 主动脉瓣反流 二尖瓣反流 危重心脏瓣膜病 介入瓣膜 

分 类 号：R654.2[医药卫生—外科学]